High-throughput approaches to discover novel immunomodulatory agents for cancer

DSpace/Manakin Repository

High-throughput approaches to discover novel immunomodulatory agents for cancer

Citable link to this page

 

 
Title: High-throughput approaches to discover novel immunomodulatory agents for cancer
Author: McMillin, Douglas William; Mitsiades, Constantine S

Note: Order does not necessarily reflect citation order of authors.

Citation: McMillin, Douglas William, and Constantine S. Mitsiades. 2012. High-throughput approaches to discover novel immunomodulatory agents for cancer. Oncoimmunology 1(8): 1406-1408.
Full Text & Related Files:
Abstract: The clinical success of immunomodulatory thalidomide derivatives has renewed the general interest in immunomodulatory anticancer compounds and prompted us to develop a high-throughput system to quantify immune effector-cell activity. We documented that the interaction between cancer cells, their stroma, anticancer agents and cells from the innate system are critical for determining the response of tumors to immunomodulatory strategies.
Published Version: doi:10.4161/onci.21058
Other Sources: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3518518/pdf/
Terms of Use: This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAA
Citable link to this page: http://nrs.harvard.edu/urn-3:HUL.InstRepos:10581973
Downloads of this work:

Show full Dublin Core record

This item appears in the following Collection(s)

 
 

Search DASH


Advanced Search
 
 

Submitters